• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer.

作者信息

Chiang Cho-Han, Xu Xiaocao, Song Junmin, Xanthavanij Nutchapon, Chi Kuan-Yu, Chang Yu-Cheng, Chang Yu, Hsiao Chieh-Lien, Chiang Cho-Hung, Lin Shuwen

机构信息

Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, USA.

Division of Hematology and Oncology, Department of Medicine, University of Vermont Medical Center, Burlington, VT, USA.

出版信息

Thromb Res. 2024 Oct;242:109119. doi: 10.1016/j.thromres.2024.109119. Epub 2024 Aug 17.

DOI:10.1016/j.thromres.2024.109119
PMID:39167941
Abstract
摘要

相似文献

1
The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer.帕博利珠单抗与乳腺癌患者静脉血栓栓塞风险之间的关联。
Thromb Res. 2024 Oct;242:109119. doi: 10.1016/j.thromres.2024.109119. Epub 2024 Aug 17.
2
Pembrolizumab in the Treatment of Breast Cancer.帕博利珠单抗治疗乳腺癌
N Engl J Med. 2022 Jul 21;387(3):273-274. doi: 10.1056/NEJMe2207532.
3
Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的癌症相关血栓形成患者的风险因素。
Invest New Drugs. 2020 Aug;38(4):1200-1206. doi: 10.1007/s10637-019-00881-6. Epub 2019 Dec 10.
4
Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the gene polymorphism.基因多态性患者接受帕博利珠单抗治疗转移性乳腺癌时并发噬血细胞性淋巴组织细胞增生症。
J Med Genet. 2019 Jan;56(1):39-42. doi: 10.1136/jmedgenet-2018-105485. Epub 2018 Oct 4.
5
A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia.
Eur J Cancer. 2019 May;112:94-97. doi: 10.1016/j.ejca.2019.02.006. Epub 2019 Apr 4.
6
Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.帕博利珠单抗诱导的肺腺癌患者胆汁淤积性肝损伤
Intern Med. 2019;58(22):3283-3287. doi: 10.2169/internalmedicine.2591-18. Epub 2019 Nov 15.
7
Pembrolizumab-induced mucositis in a patient with recurrent hypopharynx squamous cell cancer.帕博利珠单抗致复发性下咽鳞癌患者黏膜炎。
Laryngoscope. 2020 Apr;130(4):E140-E143. doi: 10.1002/lary.28038. Epub 2019 May 10.
8
An unknown reaction to pembrolizumab: giant cell arteritis.帕博利珠单抗的一种未知反应：巨细胞动脉炎。
Ann Oncol. 2017 Oct 1;28(10):2621-2622. doi: 10.1093/annonc/mdx306.
9
Immune-related adverse events after a single dose of pembrolizumab.
Eur J Cancer. 2021 May;148:92-94. doi: 10.1016/j.ejca.2021.01.048. Epub 2021 Mar 16.
10
Acute Tubulointerstitial Nephritis: A Case Report on Rare Adverse Effect of Pembrolizumab.急性肾小管间质性肾炎：帕博利珠单抗罕见不良反应病例报告。
Medicina (Kaunas). 2019 May 21;55(5):176. doi: 10.3390/medicina55050176.

引用本文的文献

1
Thromboinflammatory pathways in breast cancer: clinical and molecular insights into venous thromboembolism risk - a narrative review.乳腺癌中的血栓炎症途径：静脉血栓栓塞风险的临床与分子见解——一篇叙述性综述
Ann Med Surg (Lond). 2025 Jul 25;87(9):5822-5828. doi: 10.1097/MS9.0000000000003644. eCollection 2025 Sep.
2
Cardiovascular and thromboembolic outcomes with immune checkpoint inhibitors in gastroesophageal cancer: a propensity score-matched cohort study.免疫检查点抑制剂用于食管癌的心血管和血栓栓塞结局：一项倾向评分匹配队列研究
Gastric Cancer. 2025 May;28(3):550-555. doi: 10.1007/s10120-025-01582-1. Epub 2025 Jan 22.